OpenURL Connection Search

Select item for more details and to access through your institution.

Efficacy and safety of sacubitril/valsartan in patients with essential hypertension uncontrolled by olmesartan: A randomized, double-blind, 8-week study.
Published in:
2018
By:
- Cheung, Deanna G.;
- Aizenberg, Diego;
- Gorbunov, Vladimir;
- Hafeez, Kudsia;
- Chen, Chien‐Wei;
- Zhang, Jack;
- Chen, Chien-Wei
Publication type:
journal article
Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis.
Published in:
Diabetes Care, 2022, v. 45, n. 12, p. 2991, doi. 10.2337/dc22-0294
By:
- Rossing, Peter;
- Anker, Stefan D.;
- Filippatos, Gerasimos;
- Pitt, Bertram;
- Ruilope, Luis M.;
- Birkenfeld, Andreas L.;
- McGill, Janet B.;
- Rosas, Sylvia E.;
- Joseph, Amer;
- Gebel, Martin;
- Roberts, Luke;
- Scheerer, Markus F.;
- Bakris, George L.;
- Agarwal, Rajiv;
- AizenbergDiegoBartolacciInésBesadaDiegoBittarJulioChahinMarianoElbertAliciaGelerszteinElizabethLibermanAlbertoMaffeiLauraPérez ManghiFedericoSanabriaHugoVallejosAugustoViñesGloriaWassermannAlfredoAbhayaratnaWalterAcharyaShamasunderEkinciEli;
- Aizenberg, Diego;
- Bartolacci, Inés;
- Besada, Diego;
- Bittar, Julio;
- Chahin, Mariano
Publication type:
Article
Effect of Dapagliflozin in DAPA-HF According to Background Glucose-Lowering Therapy.
Published in:
2020
By:
- Docherty, Kieran F.;
- Jhund, Pardeep S.;
- Bengtsson, Olof;
- DeMets, David L.;
- Inzucchi, Silvio E.;
- Køber, Lars;
- Kosiborod, Mikhail N.;
- Langkilde, Anna Maria;
- Martinez, Felipe A.;
- Sabatine, Marc S.;
- Sjöstrand, Mikaela;
- Solomon, Scott D.;
- McMurray, John J.V.;
- Diez, Mirta;
- Sassone, Sonia;
- Aizenberg, Diego;
- Talavera, Maria;
- Mercau, Guillermo;
- Martinez, Diego;
- Albisu, Juan
Publication type:
journal article

Found: 3

Efficacy and safety of sacubitril/valsartan in patients with essential hypertension uncontrolled by olmesartan: A randomized, double-blind, 8-week study.

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis.

Effect of Dapagliflozin in DAPA-HF According to Background Glucose-Lowering Therapy.